Cybin Inc. (OTCMKTS:CLXPF – Get Free Report)’s share price traded up 1.9% during mid-day trading on Wednesday . The company traded as high as $10.00 and last traded at $9.77. 167,086 shares were traded during mid-day trading, a decline of 70% from the average session volume of 551,962 shares. The stock had previously closed at $9.59.
Cybin Price Performance
The stock has a market cap of $1.45 billion and a price-to-earnings ratio of -40.71. The firm’s 50-day moving average is $9.79 and its 200 day moving average is $6.63.
About Cybin
Cybin Inc, a life sciences company, focuses on developing psychedelic therapeutics to treat various psychiatric and neurological conditions. The company operates through two segments, Serenity Life and Natures Journey. The Serenity Life segment engages in the research and development of pharmaceutical and nutraceutical psilocybin products.
See Also
- Five stocks we like better than Cybin
- Insider Buying Explained: What Investors Need to Know
- How to Short Sell Stocks Like a Pro: Strategies and Tips
- How to Invest in Insurance Companies: A Guide
- 3 Steel Stocks Soaring After Tariff Announcements
- What is the Euro STOXX 50 Index?
- Top Analysts’ Picks for 2025: 3 of Morgan Stanley’s Favorites
Receive News & Ratings for Cybin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cybin and related companies with MarketBeat.com's FREE daily email newsletter.
